Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings is a research paper published in Advances in Therapy (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Aging
Grant: 1R13AG082492-01
The Amyloidosis Forum: Advancing Drug Development in ATTR Amyloidosis in an Evolving Treatment Landscape.
NHLBI NIH HHS
Grant: R01 HL139671
NIA NIH HHS
Grant: R01 AG081582
NIA NIH HHS
Grant: R13 AG082492
National Institutes of Health
Grant: 5R01AG081582-02
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
National Institutes of Health
Grant: 5R01HL139671-04
SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations)
FWCI
1.13
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals